Učitavanje...
Immunotherapy for hematological malignancies
Tumor immune tolerance remains a major barrier for effective anti-cancer therapy. A growing number of pathways whereby solid tumors escape immune surveillance have been characterized (1). This progress led us to revisit the “hallmarks of cancer” and brought forward many promising immunotherapies. Ev...
Spremljeno u:
| Izdano u: | J Life Sci (Westlake Village) |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709701/ https://ncbi.nlm.nih.gov/pubmed/31453573 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|